FDA approves Akcea rare disease drug with a black box warning
The FDA approved Akcea’s drug inotersen, which aimed to treat a rare disease known as hATTR — a major win for the company after the FDA rejected a similar drug…
Akcea Therapeutics finally earned a U.S. drug approval. The Food and Drug Administration announced Friday it had approved the company’s drug, inotersen (Tegsedi), which aims to treat a rare and fatal condition known as hATTR.
It’s a major win for Akcea, after the FDA another of the company’s drugs, Waylivra, based on the
